Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesLong-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease
Journal of Hepatology, 09/09/09
Nozaki Y et al. – Combination therapy with EZ and AC for 24 weeks improved the histopathological findings in a model of NAFLD.
Related Articles
Non-alcoholic fatty liver disease from pathogenesis to management: an update
Obesity Reviews, 11/02/09
Relevance Score: 91%
Variants in the UGT1A1 Gene and the Risk of Pediatric Nonalcoholic Fatty Liver Disease
Pediatrics, 12/02/09
Relevance Score: 88%
Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Clinical Gastroenterology and Hepatology, 11/05/09
Relevance Score: 84%
Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease
Hepatology, 11/04/09
Relevance Score: 84%
Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome
Journal of Hepatology, 11/04/09
Relevance Score: 84%
Today in Hepatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Thiazolidinediones and the liver in humans
Current Opinion in Lipidology, 12/14/09
Food allergy after liver transplantation in children: a prospective study
Pediatric Allergy and Immunology, 12/14/09
Recurrent acute hepatic dysfunction in severe anorexia nervosa
International Journal of Eating Disorders, 12/14/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Vascular Endothelial Growth Factor Plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism
Journal of Oncology, 12/14/09
An Unusual Cause of Hematemesis
Clinical Gastroenterology and Hepatology , 12/14/09
Palliative treatment of unresectable metastatic colorectal cancer
Expert Opinion in Pharmacotherapy, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor